National Cervical Screening Program monitoring report 2023
Citation
AIHW (Australian Institute of Health and Welfare) (2023) National Cervical Screening Program monitoring report 2023, AIHW, Australian Government, accessed 22 June 2026, doi:10.25816/d4r6-h445.
PDF | 2MB
This is the fifth report to monitor the National Cervical Screening Program since it introduced 5-yearly HPV tests in December 2017. In 2018–2022, there were more than 5.2 million participants aged 25–74, and in 2022, 10% of screening HPV tests performed were positive for HPV types that cause cervical cancer. Cervical cancer incidence and mortality remained low at 11 new cases and 2 deaths per 100,000 women, respectively.
- ISBN: 978-1-923085-51-0
- DOI: 10.25816/d4r6-h445
- Cat. no: CAN 157
- Pages: 196
-
More than 5.2 million cervical screening participants aged 25–74 in 2018–2022
-
Cervical screening HPV test positivity was 10% in 2022
-
869 females aged 25–74 were diagnosed with cervical cancer in 2019
-
179 females aged 25–74 died from cervical cancer in 2021
